[Federal Register Volume 66, Number 50 (Wednesday, March 14, 2001)]
[Notices]
[Page 14904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-6298]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Scientific Consultation: Meeting

    The Centers for Disease Control and Prevention (CDC) announces the 
following meeting:

    Name: Protocol Review for Neurodevelopmental Evaluation Study.
    Times and Dates: 10:30 a.m.-5:30 p.m., March 26, 2001; 8:30 
a.m.-3:30 p.m., March 27, 2001.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, GA 30345-3377. Telephone: (404) 325-0000.
    Status: Open to the public, limited only by space available.
    Purpose: The Centers for Disease Control and Prevention 
announces a meeting of expert consultants.
    Matters to be Discussed: The agenda will include the review and 
discussion on the design of a protocol for a neurodevelopmental 
examination study looking at thimerosal containing vaccines and the 
possible association with selected neurodevelopmental outcomes. A 
period for public comment will be made available each day. 
Individuals wishing to provide public comment should notify the 
contact person listed in this announcement.
    Contact Person for More Information: Gina Mootrey, D.O., M.P.H., 
Senior Research Officer, Vaccine Safety and Development Activity, 
Epidemiology and Surveillance Division, National Immunization 
Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, Georgia 
30333. Telephone (404)639-8256.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 8, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 01-6298 Filed 3-13-01; 8:45 am]
BILLING CODE 4163-18-U